Recent News About Calimmune
By Kathy Adams | Nov 20, 2016
Calimmune Inc., a clinical-stage gene therapy company, has appointed Dr. Salim Yazji as executive vice president and chief medical officer.
By Kathy Adams | Nov 20, 2016